Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1900 of 3284 entries
View as:

Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00608218 Org: User:
Start: 01/31/08 End: 08/31/08 Due: 08/31/09

A Study of AZD8233 in Participants With Dyslipidemia.

Phase: N/A Priority: Normal
NCT ID: NCT04823611 Org: User:
Start: 01/20/21 End: 09/10/22 Due: 09/10/23

A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01957579 Org: User:
Start: 05/25/11 End: 09/15/15 Due: 09/15/16

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

Phase: N/A Priority: Normal
NCT ID: NCT04421963 Org: User:
Start: 08/04/20 End: 04/06/27 Due: 04/06/28

The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA)

Phase: N/A Priority: Normal
NCT ID: NCT06056778 Org: User:
Start: 09/28/23 End: 06/17/24 Due: 06/17/25

An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication

Phase: N/A Priority: Normal
NCT ID: NCT00577265 Org: User:
Start: 11/30/04 End: - Due: -

A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05683977 Org: User:
Start: 11/14/22 End: 03/01/27 Due: 03/01/28

High Doses of Candesartan Cilexetil on the Reduction of Proteinuria

Phase: N/A Priority: Normal
NCT ID: NCT00242346 Org: User:
Start: 04/30/03 End: 12/31/06 Due: 12/31/07

Prospective Tissue Collection Research Protocol

Phase: N/A Priority: Normal
NCT ID: NCT03517917 Org: User:
Start: 02/08/18 End: 10/08/24 Due: 10/08/25

Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study

Phase: N/A Priority: Normal
NCT ID: NCT06521229 Org: User:
Start: 06/27/24 End: 03/31/26 Due: 03/31/27

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00972049 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00274469 Org: User:
Start: 02/06/06 End: 01/13/17 Due: 01/13/18

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

Phase: N/A Priority: Normal
NCT ID: NCT00679640 Org: User:
Start: 01/31/08 End: 07/31/10 Due: 07/31/11

Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient

Phase: N/A Priority: Normal
NCT ID: NCT01213160 Org: User:
Start: 11/30/10 End: 06/30/13 Due: 06/30/14

Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04449484 Org: User:
Start: 08/04/20 End: 01/05/22 Due: 01/05/23

Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

Phase: N/A Priority: Normal
NCT ID: NCT00812357 Org: User:
Start: 04/30/09 End: 08/31/11 Due: 08/31/12

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03263637 Org: User:
Start: 10/24/17 End: 09/30/21 Due: 09/30/22

Assessment of MDD Management in Andalusia

Phase: N/A Priority: Normal
NCT ID: NCT01510886 Org: User:
Start: 06/30/12 End: 09/30/13 Due: 09/30/14

Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01415778 Org: User:
Start: 08/31/11 End: 12/31/11 Due: 12/31/12

Study to Assess Osimertinib in Patients w/ Adv Solid Tumours & Normal Kidney Function or Severe Kidney Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02923947 Org: User:
Start: 05/04/17 End: 10/28/22 Due: 10/28/23

RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.

Phase: N/A Priority: Normal
NCT ID: NCT05180357 Org: User:
Start: 11/23/21 End: 10/28/22 Due: 10/28/23

Dapagliflozin DPPIV Inhibitor add-on Study

Phase: N/A Priority: Normal
NCT ID: NCT00984867 Org: User:
Start: 10/31/09 End: 09/30/11 Due: 09/30/12

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT06057064 Org: User:
Start: 09/29/23 End: 05/17/24 Due: 05/17/25

SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT05141201 Org: User:
Start: 12/21/21 End: 11/30/25 Due: 11/30/26

Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03371459 Org: User:
Start: 12/29/17 End: 03/26/18 Due: 03/26/19